Summit Therapeutics (SMMT) - 2025 FY - Earnings Call Transcript

Summit Therapeutics (SMMT) FY 2025 Conference June 09, 2025 01:20 PM ET Speaker0 Great. Good afternoon, everyone. Thank you so much for joining us. I'm Salveen Richter, Biotechnology Analyst at Goldman Sachs. And we're really pleased to be joined by the Summit team who's rather patriotic today. So to start here next to me, have Mickey Zengene, who's Co CEO Bob Duggan, Co CEO Manmeet, Sony, COO and CFO and Dave Genzar's Chief Business Officer. So with that, to start here, could you provide an overview of you ...